Combination of cytokine responses indicative of latent TB and active TB in malawian adults

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Hur, Yun Gyoung ^a   Gorak Stolinska, Patricia ^a   Ben Smith, Anne ^a,b   Lalor, Maeve K ^a   Chaguluka, Steven ^b   Dacombe, Russell ^a,b   Doherty, T Mark ^c   Ottenhoff, Tom H ^d   Dockrell, Hazel M ^a   Crampin, Amelia C ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

^c GSK   (Denmark)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHEMOKINE CXCL10; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LATENT TUBERCULOSIS; MALAWI; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SPUTUM; TUBERCULIN; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894156206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079742     Document Type: Article

References (29)

1. WHO (2011) Global Tuberculosis Control 2011. Available: http://www.who.int/tb/publications/global-report/2011/gtbr11-full.pdf. Accessed 25 January 2013.
2. Onyebujoh P, Rook GA (2004) Tuberculosis. Nat Rev Microbiol 2(12): 930-932. (Pubitemid 39562531)
3. Pai M, Riley LW, Colford JM (2004) Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776.
4. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G (2009) Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 9: 21.
5. Claessens NJ, Gausi FF, Meijnen S, Weismuller MM, Salaniponi FM, et al. (2002) High frequency of tuberculosis in households of index TB patients. Int J Tuberc Lung Dis 6(3): 266-269. (Pubitemid 34270106)
6. Crampin AC, Floyd S, Ngwira BM, Mwinuka V, Mwaungulu JN, et al. (2008) Assessment and evaluation of contact as a risk factor for tuberculosis in rural Africa. Int J Tuberc Lung Dis 12(6): 612-618. (Pubitemid 351846757)
7. Crampin AC, Kasimba S, Mwaungulu NJ, Dacombe R, Floyd S, et al. (2011) Married to M. tuberculosis: risk of infection and disease in spouses of smearpositive tuberculosis patients. Trop Med Int Health 16(7): 811-818.
8. Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, et al. (2001) Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis 5: 664-672. (Pubitemid 32652157)
9. Black GF, Thiel BA, Ota MO, Parida SK, Adegbola R, et al. (2009) Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 16: 1203-1212.
10. Franken KL, Hiemstra HS, van Meijgaarden KE, Subronto Y, den Hartigh J, et al. (2000) Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 18: 95-99. (Pubitemid 30097778)
11. Lalor MK, Ben-Smith A, Gorak-Stolinska P, Weir RE, Floyd S, et al. (2009) Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J Infect Dis 199: 795-800.
12. Dana Mazo (2007) Interferon-gamma responses in spouses of sputum smear positive tuberculosis cases in Malawi. London: London School of Hygiene & Tropical Medicine.
13. Kobashi Y, Shimizu H, Ohue Y, Mouri K, Obase Y, et al. (2010) Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis- specific antigens in patients with active and latent tuberculosis. Lung 188(4): 283-287.
14. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. (2009) IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes 2: 19-24.
15. Chen DY, Shen GH, Chen YM, Chen HH, Lin CC, et al. (2011) Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Int J Tuberc Lung Dis 15(2): 192-200.
16. Beamer GL, Flaherty DK, Assogba BD, Stromberg P, Gonzalez-Juarrero M, et al. (2008) Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 181(8): 5545-5550.
17. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39(3): 723-729.
18. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL- 23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8(4): 369-377. (Pubitemid 46745412)
19. Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, et al. (2008) Distinct, specific IL-17- and IL-22-producing CD4 + T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180(3): 1962-1970.
20. Ottenhoff TH (2012) New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol 20: 419-428.
21. Perreau M, Rozot V, Welles HC, Belluti-Enders F, Vigano S, et al. (2013) Lack of Mycobacterium tuberculosis -specific interleukin-17A-producing CD4(+) T cells in active disease. Eur J Immunol 43(4): 939-948.
22. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17(3): 372-376.
23. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, et al. (2010) Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 40: 2211-2220.
24. Weiner J, 3rd, Parida SK, Maertzdorf J, Black GF, Repsilber D, et al. (2012) Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS One 7(7): e40221.
25. Fine PE, Sterne JA, Ponnighaus JM, Rees RJ. (1994) Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344(8932): 1245-1249. (Pubitemid 24334679)
26. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis -specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40(2): 704-706. (Pubitemid 34130912)
27. Brock I, Munk ME, Kok-Jensen A, Andersen P (2001) Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 5: 462-467. (Pubitemid 32397571)
28. Arend SM, Andersen P, van Meijgaarden KE, Skjot RL, Subronto YW, et al. (2000) Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 181: 1850-1854. (Pubitemid 30387793)
29. Borgstrom E, Andersen P, Atterfelt F, Julander I, Kallenius G, et al. (2012) Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker. PLoS One 7: e43438.